Life Science Leader Magazine Supplements

CRO Supplement 2015

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 8 of 51

9 LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2015 we continue to go it alone – the game- changing opportunities that require true leadership. How can pharma companies better organize to support innovation in their organizations? Can you share a few best practices? KASHER: In many organizations the inno- vation group seems to be decoupled from the molecule development teams. This creates a situation where every innovative pilot must be shopped to multiple teams in hopes of finding one who will agree to participate. Implementation of innova- tion requires an organization where the culture expects/encourages/desires that innovation is piloted and then scaled, if is the domain of sponsors. Over the last decade we've seen some blurring of those distinctions, especially in the discovery space. But if sponsors and their CRO partners can implement truly effective processes for evaluating and acting on innovation, there's no reason that novel ideas from any source can't be acted on appropriately in a joint fashion. LIPSET: I think Frances makes some really great points. An old proverb states if you want to go fast, go alone; if you want to go far, go together. The prolif- eration of collaborations today begins to violate this proverb — initiatives such as TransCelerate are bringing together highly motivated and like-minded peers across companies showing an ability to defy the rule that going together sacrifices speed. Collaboration is the new baseline, but we must continue to differentiate and challenge boundaries. The latter is where conduct. A robust process for making the most of innovation should allow for rapid evaluation based on clear busi- ness cases, empowered decision-making, and prioritization based on the ability to adequately support projects. Historically our industry has operated on the premise that CROs can contribute to operational innovation, but that scientific expertise Our industry continues to lag in maximizing the use of technology. F R A N C E S G R O T E

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Supplement 2015